While the markets closed the second quarter higher, the Dow plunged 114 points today to end June at 14,909. Nasdaq edged up a point to 3403.
On the upside
Prosensa Holding (Nasdaq: RNA) stock surged nearly 50% on its first trading day.
The European Medicines Agency Committee for Medicinal Products for Human Use granted a positive recommendation for the subcutaneous formulation of Herceptin, developed jointly by Halozyme Therapeutcs (Nasdaq: HALO) and Roche.
On the downside
Oppenheimer initiated coverage of Palo Alto Networks (NYSE: PANW) with a Perform rating.
Citigroup downgraded Owens Corning (NYSE: OC) to a Neutral rating from a Buy rating.
OvaScience (Nasdaq: OVAS) chief executive Michelle Dipp, M.D., Ph.D. will present at the Encuentros 2013: Inspiring Innovation conference at the MIT Media Lab this evening.
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 index fell 6 points to 1606.